An evidence-based review of natalizumab therapy in the management of Crohn’s disease by Raja GR Edula, Michael F Picco

Get full text

The use of chromoendoscopy for surveillance of inflammatory bowel disease by Gary R. Lichtenstein, MD, Michael F. Picco, MD, PhD, Sanjeev Solomon, MD, Stephen J. Bickston, MD

Get full text

Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease by William A Faubion, Rodney D Newberry, Ming-Hsi Wang, Jessica J Friton, Laura E Raffals, Jonathan A Leighton, Shabana F Pasha, Michael F Picco, Kelly Monroe, Billy D Nix

Get full text